The ingredient has low viscosity and unique water-withholding capabilities.
Artinia, a chitin-glucan fiber with cardiovascular benefits especially for LDL cholesterol, was tested in extruded breakfast cereal and exhibited “remarkable” sensory and physical characteristics, reports the ingredient’s firm Stratum Nutrition (St. Louis, MO).
Stratum says that Artinia in cereal provided functional benefits such as lowering the cereal’s “solubility, therefore creating ‘less sogginess.’”
“The higher the inclusion rate of Artinia in the extruded cereal, the higher the porosity, and thus, the Textural Peak Force-i.e., the ‘crunchiness’-was improved,” the company states.
The cereal trial was performed in collaboration with the Wenger Technical Research Facility (Sabetha, KS) and the Food Processing Center at the University of Nebraska-Lincoln.
This past June, Stratum Nutrition also reported that Artinia exhibited excellent sensory and quality ratings in baked goods-such as bread, muffins, and cookies-in trials performed by the American Institute of Baking.
Stratum said that in terms of sensory attributes, Artinia may work better as a “drop-in” ingredient compared to other fibers, and may also require less energy to make dough-particularly because of the ingredient’s low viscosity and unique water-withholding capabilities.
“Artinia is a highly flexible ingredient to work with, where it can easily be added to batter, dough, or sponge, without reformulation,” the company said. “By simply adding Artinia to an existing formula, adjusting the water level, blending, and baking, the dough responds positively to mixing, handling, and machining.”
Artinia was self-affirmed GRAS for food and beverages last year.
Meta-analysis does not find increased risk of bleeding events from omega-3 PUFA consumption
July 8th 2024Researchers reviewed 11 studies and found that there was no difference in the incidence of bleeding events between patients receiving omega-3 PUFAs and those not receiving them. High dose EPA consumption was associated with an elevated but modest risk.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
Recent review makes the case for testing omega-3 fatty acid levels in humans
May 23rd 2024The article commissioned by The Global Organization for EPA and DHA Omega-3s (GOED) reviewed the state of omega-3 fatty acid testing, highlighting the value of testing and the commercially available options for diagnostic testing.
Epax launches concentrated oil that combines omegas 3, 9, and 11
May 10th 2024The blend of long-chain polyunsaturated fatty acids and long-chain monounsaturated fatty acids combines the heart and brain health benefits of omegas-3s with the skin and metabolic health benefits of omegas 9 and 11.